Tendie.bot
Daily Tendie Bot stock recaps and market discussion articles for CAPR.
Capricor Therapeutics (CAPR) surged over 60% after-hours following Q2 earnings and an FDA confirmation that it will review an amended BLA for Deramiocel. Retail traders on r/Shortsqueeze are calling it a massive short squeeze setup, citing trapped short sellers and strong cash reserves.